Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Maintenance Dose

<< Previous

Bullboard Posts

Next >>

Comment by RoseHeavenon Jun 30, 2022 12:54pm

122 Views

Post# 34794227

RE:RE:RE:RE:RE:RE:RE:Maintenance Dose

Still the questions remained about the # of patients and maintenance dosage:

1) 5 did not get 2nd treatment from 12 underdosed patients
2) 1 patient died

This makes a total of 6, but the total number of patients did not get 2nd dose is 12 as indicated in May 30 Management Discussion.

Where this remmaining 6 is coming from?

Any thoughts?

<< Previous

Bullboard Posts

Next >>

Pro Women’s Hockey League comes to NHL 25 in December